Literature DB >> 17255892

Aggressiveness in cholesterol granuloma of the temporal bone may be determined by the vigor of its blood source.

Markus H F Pfister1, Robert K Jackler, Larisa Kunda.   

Abstract

OBJECTIVE: Recently, it has been proposed that the aggressive behavior of cholesterol granuloma (CG) of the petrous apex is explained by its proximity to the richly vascular marrow of the petroclival junction. Most CGs of the lateral temporal bone are indolent. The purpose of the present study is to examine the factors responsible for atypical aggressive behavior in mastoid CG. STUDY
DESIGN: Retrospective case series.
SETTING: : Tertiary academic practice. PATIENT POPULATION: Four patients with atypically aggressive CG of the mastoid.
RESULTS: In each case, the CG abutted a rich blood source: the sigmoid sinus, carotid artery, a large dural vein, or a rich deposit of vascular marrow in the mastoid tip.
CONCLUSION: These observations lend further support to the theory that aggressiveness of CG is sustained by a robust source of ongoing hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255892     DOI: 10.1097/MAO.0b013e31802bea4b

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  3 in total

1.  Petrous apex cholesterol granuloma: maintenance of drainage pathway, the histopathology of surgical management and histopathologic evidence for the exposed marrow theory.

Authors:  Michael Hoa; John W House; Fred H Linthicum
Journal:  Otol Neurotol       Date:  2012-08       Impact factor: 2.311

2.  Tympanomastoid cholesterol granuloma: radiological and intraoperative findings of blood source connection.

Authors:  Giannicola Iannella; Alessandro Stasolla; Benedetta Pasquariello; Massimo Re; Giuseppe Magliulo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-31       Impact factor: 2.503

3.  Large Cholesterol Granuloma of the Middle Ear Eroding into the Middle Cranial Fossa.

Authors:  Tessei Kuruma; Tohru Tanigawa; Yasue Uchida; Ogawa Tetsuya; Hiromi Ueda
Journal:  Case Rep Otolaryngol       Date:  2017-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.